View Older Stories

Jan 16, 2026 12:01PM FDA grants Breakthrough Therapy status to Novartis ianalumab for Sjögren's

Jan 13, 2026 03:07PM Novartis licenses peptide asset from PepLib for radioligand therapy

Jan 6, 2026 01:37PM Barclays Upgrades Novartis (NVS) to Equalweight

Dec 31, 2025 06:01AM Drugmakers Raise Us Prices On 350 Medicines Despite Pressure From Trump - Reuters

Dec 19, 2025 02:32PM Novartis reaches agreement with US government on drug pricing measures

Dec 19, 2025 02:24PM 14 of 17 Leading Drug Manufactures Now Part of Trump Most Favored Nation Efforts

Dec 19, 2025 02:21PM Trump to announce prescription drug price agreements

Dec 19, 2025 08:51AM White House: Trump on Friday to announce more 'deals that will lower prices of drugs and pharmaceuticals'

Dec 17, 2025 09:00AM Novartis selects Salesforce Agentforce for global customer engagement

Dec 12, 2025 07:03AM Novartis breaks ground on North Carolina manufacturing hub

Dec 9, 2025 07:33AM Novartis reports positive Phase III results for ITP treatment combo

Dec 9, 2025 07:16AM Novartis reports long-term breast cancer treatment data at medical meeting

Dec 3, 2025 04:13AM Morgan Stanley Upgrades Novartis (NOVN:SW) (NVS) to Overweight

Dec 1, 2025 06:53AM UK and US poised to agree zero-tariffs deal on pharmaceuticals - The Times

Nov 25, 2025 03:37AM BofA Securities Upgrades Novartis (NOVN:SW) (NVS) to Buy

Nov 24, 2025 09:05AM TD Cowen on Novartis (NVS): 'Meet Management Meeting Showcases Growth Drivers And Pipeline'

Nov 19, 2025 12:36PM Novartis plans $23 billion US manufacturing expansion creating 700 North Carolina jobs

Nov 17, 2025 08:30AM The Race for the Global Radiotherapy Cancer Market; Actinium Pharmaceuticals' (ATNM) Big Bet

Nov 12, 2025 05:01PM Novartis malaria drug meets primary endpoint in phase III trial

Nov 10, 2025 09:31AM Novartis opens radioligand therapy manufacturing facility in California

Nov 10, 2025 08:36AM TD Cowen on Novartis (NVS): 'Meetings With Management Highlight Multiple Drivers Of Business Momentum'

Nov 10, 2025 04:51AM TD Cowen Reiterates Hold Rating on Novartis (NOVN:SW) (NVS)

Oct 29, 2025 11:42AM Novartis (NVS) PT Raised to $126 at CFRA

Oct 29, 2025 10:31AM Novartis presents positive ianalumab data for Sjogren's disease

Oct 28, 2025 09:58AM Novartis completes acquisition of Tourmaline Bio

Oct 28, 2025 06:01AM Deutsche Bank Reiterates Buy Rating on Novartis (NOVN:SW) (NVS)

Oct 28, 2025 02:41AM Novartis (NVS) Misses Q3 EPS by 2c; offers outlook

Oct 27, 2025 04:00PM Novartis Q3 preview: BofA sees strong product momentum, potential EBIT Upgrade

Oct 27, 2025 06:20AM H.C. Wainwright Downgrades Avidity Biosciences (RNA) to Neutral Post Novartis Acquisition

Oct 27, 2025 12:28AM Novartis to acquire Avidity Biosciences for $12 billion or $72 per share cash

Oct 26, 2025 11:32AM Novartis Said To Near Deal $70-per-share-plus Deal For Avidity Biosciences (RNA) - Bloomberg

Oct 17, 2025 08:03AM Novartis reports sustained benefit from Kisqali in breast cancer trial

Oct 17, 2025 06:43AM Novartis receives positive EMA opinion for Scemblix CML treatment

Sep 30, 2025 04:16PM Novartis receives FDA approval for oral CSU treatment Rhapsido

Sep 29, 2025 07:32AM M. Stanley cuts Novo Nordisk to Underweight on ’tough path ahead’, shares slip

Sep 26, 2025 01:39PM EU will still have 15% pharma tariff, not 100% - Bloomberg

Sep 24, 2025 04:01AM Novartis presents Kesimpta data showing disease activity reduction in MS patients

Sep 15, 2025 08:16AM Monte Rosa surges premarket on Novartis collaboration deal

Sep 12, 2025 12:55AM Goldman Sachs Downgrades Novartis (NOVN:SW) (NVS) to Sell

Sep 3, 2025 07:00AM Argo Biopharma signs $160 million deal with Novartis for heart drugs

Aug 21, 2025 03:34AM Novartis (NOVN:SW) (NVS) PT Raised to CHF120 at Deutsche Bank

Aug 8, 2025 02:53AM Morgan Stanley Upgrades Novartis (NVS) to Equalweight

Aug 6, 2025 11:23AM Novartis (NVS) Made A Takeover Approach Avidity Biosciences (RNA) - FT

Jul 31, 2025 01:49PM Trump Posts Letters to Regeneron, Merck, AstraZeneca, GSK, Pfizer, Novo Nordisk, Amgen, Bristol-Myears, AbbVie, Novartis, Gilead, J&J on Truth Social

Jul 17, 2025 03:19AM Novartis (NVS) Tops Q2 EPS by 7c; raises FY guidance

Jul 11, 2025 11:30AM Novartis (NVS) Failed To Prove Infringement At Delaware Bench Trial - Bloomberg

Jul 3, 2025 11:15AM Novartis (NVS) provides update on Phase III GCAptAIN study of Cosentyx in giant cell arteritis

Jun 20, 2025 11:08AM Several Forms Of Generic Ritalin Fail To Work Correctly: Study - Bloomberg

Jun 3, 2025 06:01AM Wegovy Use Up 50% Among Us Teens - Reuters

May 22, 2025 11:34AM Citi Reiterates Sell Rating on Hims and Hers (HIMS), Comments on Novo's Wegovy Price Promo: 'We see this as another potential headwind for HIMS

View Older Stories